---
title: Diagnostic and Severity-Tracking Biomarkers for Autism Spectrum Disorder
type: pub
encoding: UTF-8

---
<h1>Publication</h1>
<article id="csl-bib-container-SUXCLJN7" class="csl-bib-container">
  <div class="csl-bib-body"> <div class="csl-entry">Bjørklund, G., Meguid, N. A., El-Ansary, A., El-Bana, M. A., Dadar, M., Aaseth, J., Hemimi, M., Osredkar, J., &#38; Chirumbolo, S. (2018). Diagnostic and Severity-Tracking Biomarkers for Autism Spectrum Disorder. <i>Journal of Molecular Neuroscience</i>, 1–20. <a href="https://doi.org/10.1007/s12031-018-1192-1">https://doi.org/10.1007/s12031-018-1192-1</a></div> </div>
  <div class="csl-bib-buttons">
    <a href="#taxonomy-article-SUXCLJN7" alt="archive" class="csl-bib-button">Archive</a>
    <a href="https://app.cristin.no/results/show.jsf?id=1628271" alt="Cristin" class="csl-bib-button">Cristin</a>
    <a href="http://zotero.org/groups/5881554/items/SUXCLJN7" alt="Zotero" class="csl-bib-button">Zotero</a>
    <a href="#keywords-article-SUXCLJN7" alt="keywords" class="csl-bib-button">Keywords</a>
    <a href="#about-article-SUXCLJN7" alt="about_pub" class="csl-bib-button">About</a>
    <a href="#sdg-article-SUXCLJN7" alt="sdg" class="csl-bib-button">Sustainable Development Goals</a>
    <a href="https://doi.org/10.1007/s12031-018-1192-1" alt="Unpaywall" class="csl-bib-button">Unpaywall</a>
    <a href="https://doi.org/10.1007/s12031-018-1192-1" alt="EZproxy" class="csl-bib-button">EZproxy</a>
  </div>
  <div id="csl-bib-meta-container-SUXCLJN7"></div>
</article>
<div id="csl-bib-meta-SUXCLJN7" class="csl-bib-meta">
  <article id="about-article-SUXCLJN7" class="about_pub-article">
    <h1>About</h1>
    Bjørklund et al. conducted a comprehensive review of potential biomarkers for Autism Spectrum Disorder (ASD), a condition affecting communication, social skills, and behavior. Currently, ASD is diagnosed based on observed behaviors, which can be subjective. The authors highlight the importance of identifying clinical biomarkers—biological indicators that can improve diagnosis and treatment. They examined various biomarkers, including metabolic and genetic factors, and neuroimaging findings. Metabolic biomarkers relate to chemical processes in the body, while genetic biomarkers involve DNA variations. Although promising, genetic markers are not yet reliable due to inconsistent results. Understanding these biomarkers could lead to more accurate diagnoses and better treatment options for ASD, benefiting individuals and families by providing clearer insights into the condition's severity and progression.
  </article>
  <article id="keywords-article-SUXCLJN7" class="keywords-article">
    <h1>Keywords</h1>
    Autism Spectrum Disorder, Biomarkers, Metabolic Biomarkers, Genetic Biomarkers, Neuroimaging Abnormalities, ASD Diagnosis
  </article>
  <article id="abstract-article-SUXCLJN7" class="abstract-article">
    <h1>Scientific abstract</h1>
    Autism spectrum disorder (ASD) is a neurodevelopmental disorder afflicting about one in every 68 children. It is behaviorally diagnosed based on a triad of symptoms, including impairment in communication, impairment in sociability and abnormal and stereotypic behavior. The subjectivity of behavioral diagnosis urges the need for clinical biomarker tests to improve and complement ASD diagnosis and treatment. Over the past two decades, researchers garnered a broad range of biomarkers associated with ASD and often correlating with the severity of ASD, which includes metabolic and genetic biomarkers or neuroimaging abnormalities. Metabolic biomarkers are either involved in key pathways such as a trans-sulfuration pathway or produced due to the derangement of these pathways in the case of oxidative stress. Recent studies reported several genetic abnormalities related to ASD, encompassing various mechanisms, from copy number variations (CNVs) and single nucleotide polymorphisms (SNPs) to chromosomal anomalies. However, it is still premature to consider these genetic variants as true biomarkers for ASD, due to their low reproducibility and regional-specific nature. Herein, we comprehensively review state of the art about major biomarkers reported in ASD and the association of some biomarkers with ASD symptoms and severity. It is important to establish those biomarkers to be able to help in the diagnosis and to optimize the treatment of ASD.
  </article>
  <article id="sdg-article-SUXCLJN7" class="sdg-article">
    <h1>Sustainable Development Goals</h1>
    <div class="sdg-container"><div id="sdg3" class="sdg">
        <img src="{{< params subfolder >}}images/sdg/sdg03_en.png" class="image" alt="SDG 3">
        <div class="sdg-overlay">
          <a href="{{< params subfolder >}}en/archive/?sdg=3#archive" class="sdg-publication-count"><span>1377</span> Publications</a>
          <p><a href="https://sdgs.un.org/goals/goal3" class="sdg-read-more">Read More</a></p>
        </div>
      </div></div>
  </article>
  <article id="taxonomy-article-SUXCLJN7" class="taxonomy-article">
    <h1>Archive</h1>
    <ul>
      <li><a href="{{< params subfolder >}}en/archive/?key=3DCRN523">University of Inland Norway</a></li>
      <li><a href="{{< params subfolder >}}en/archive/?key=IDKFS3MX">Faculty of Social and Health Sciences</a></li>
      <li><a href="{{< params subfolder >}}en/archive/?key=GTV4ECMZ">Department of Health and Nursing Sciences</a></li>
      <li><a href="{{< params subfolder >}}en/archive/?key=676HMQBA">2018</a></li>
      <li><a href="{{< params subfolder >}}en/archive/?key=QBYYL8BM">November</a></li>
    </ul>
  </article>
</div>
